Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Multiple drugs

Lack of efficacy and off label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kainz M, et al. Intraoperative Off-Label Reversal of Apixaban by Andexanet Alfa while on VA-ECMO Immediately After Emergent Surgery for Acute Type A Aortic Dissection. Journal of Cardiothoracic and Vascular Anesthesia 35: 262-264, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1053/j.jvca.2020.08.017 Kainz M, et al. Intraoperative Off-Label Reversal of Apixaban by Andexanet Alfa while on VA-ECMO Immediately After Emergent Surgery for Acute Type A Aortic Dissection. Journal of Cardiothoracic and Vascular Anesthesia 35: 262-264, No. 1, Jan 2021. Available from: URL: http://​doi.​org/​10.​1053/​j.​jvca.​2020.​08.​017
Metadaten
Titel
Multiple drugs
Lack of efficacy and off label use: case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99187-1

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Brodalumab

Case report

Ribavirin